Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
6314 | 1501 | 43.9 | 90% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
109 | 2 | CHRONIC LYMPHOCYTIC LEUKEMIA//HODGKINS DISEASE//MANTLE CELL LYMPHOMA | 25223 |
6314 | 1 | DIFFUSE LARGE B CELL LYMPHOMA//DOUBLE HIT LYMPHOMA//DLBCL | 1501 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DIFFUSE LARGE B CELL LYMPHOMA | authKW | 2163840 | 29% | 25% | 433 |
2 | DOUBLE HIT LYMPHOMA | authKW | 703567 | 3% | 82% | 42 |
3 | DLBCL | authKW | 556444 | 7% | 28% | 98 |
4 | DOUBLE HIT | authKW | 263827 | 1% | 62% | 21 |
5 | BURKITT LYMPHOMA | authKW | 259530 | 5% | 17% | 74 |
6 | MYC | authKW | 165676 | 6% | 8% | 97 |
7 | LYMPHOID CANC | address | 163752 | 2% | 22% | 37 |
8 | BCL2 | authKW | 145257 | 5% | 11% | 68 |
9 | BCL6 | authKW | 137120 | 2% | 18% | 37 |
10 | TRIPLE HIT LYMPHOMA | authKW | 104613 | 0% | 86% | 6 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 28791 | 42% | 0% | 633 |
2 | Oncology | 10282 | 43% | 0% | 647 |
3 | Pathology | 7624 | 20% | 0% | 307 |
4 | Medical Laboratory Technology | 284 | 3% | 0% | 38 |
5 | Cell Biology | 172 | 8% | 0% | 113 |
6 | Medicine, Research & Experimental | 79 | 4% | 0% | 59 |
7 | Genetics & Heredity | 60 | 4% | 0% | 62 |
8 | Education, Scientific Disciplines | 21 | 1% | 0% | 12 |
9 | Medicine, General & Internal | 20 | 4% | 0% | 53 |
10 | Anatomy & Morphology | 14 | 1% | 0% | 9 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHOID CANC | 163752 | 2% | 22% | 37 |
2 | METAB BRANCH | 81429 | 3% | 8% | 51 |
3 | HEMATOPATHOL | 72854 | 6% | 4% | 93 |
4 | HEMATOPATHOL SECT | 69902 | 2% | 9% | 37 |
5 | NETWORK MOL MECH MALIGNANT LYMPHOMA MMML | 61025 | 0% | 100% | 3 |
6 | BIOINFORMAT MOL ANAL SECT | 54234 | 1% | 33% | 8 |
7 | LYMPHOID MALIGNANCIES BRANCH | 53855 | 1% | 19% | 14 |
8 | HEMATOL ONCOL MOL CELLULAR PHARMACOL | 48813 | 0% | 40% | 6 |
9 | LYMPH NODE REGISTRY | 48190 | 1% | 15% | 16 |
10 | CLIN HAEMATOL DIAGNOST | 46492 | 0% | 57% | 4 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEUKEMIA & LYMPHOMA | 27271 | 7% | 1% | 101 |
2 | JOURNAL OF HEMATOPATHOLOGY | 23422 | 1% | 10% | 11 |
3 | BLOOD | 11175 | 9% | 0% | 138 |
4 | HEMATOLOGICAL ONCOLOGY | 6850 | 1% | 2% | 17 |
5 | HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 5391 | 1% | 2% | 12 |
6 | HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 4621 | 1% | 1% | 20 |
7 | MODERN PATHOLOGY | 4584 | 2% | 1% | 33 |
8 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 4492 | 1% | 2% | 13 |
9 | BRITISH JOURNAL OF HAEMATOLOGY | 4012 | 3% | 0% | 52 |
10 | ANNALS OF HEMATOLOGY | 3426 | 2% | 1% | 25 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIFFUSE LARGE B CELL LYMPHOMA | 2163840 | 29% | 25% | 433 | Search DIFFUSE+LARGE+B+CELL+LYMPHOMA | Search DIFFUSE+LARGE+B+CELL+LYMPHOMA |
2 | DOUBLE HIT LYMPHOMA | 703567 | 3% | 82% | 42 | Search DOUBLE+HIT+LYMPHOMA | Search DOUBLE+HIT+LYMPHOMA |
3 | DLBCL | 556444 | 7% | 28% | 98 | Search DLBCL | Search DLBCL |
4 | DOUBLE HIT | 263827 | 1% | 62% | 21 | Search DOUBLE+HIT | Search DOUBLE+HIT |
5 | BURKITT LYMPHOMA | 259530 | 5% | 17% | 74 | Search BURKITT+LYMPHOMA | Search BURKITT+LYMPHOMA |
6 | MYC | 165676 | 6% | 8% | 97 | Search MYC | Search MYC |
7 | BCL2 | 145257 | 5% | 11% | 68 | Search BCL2 | Search BCL2 |
8 | BCL6 | 137120 | 2% | 18% | 37 | Search BCL6 | Search BCL6 |
9 | TRIPLE HIT LYMPHOMA | 104613 | 0% | 86% | 6 | Search TRIPLE+HIT+LYMPHOMA | Search TRIPLE+HIT+LYMPHOMA |
10 | HANS ALGORITHM | 81367 | 0% | 100% | 4 | Search HANS+ALGORITHM | Search HANS+ALGORITHM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | KORKOLOPOULOU, P , VASSILAKOPOULOS, T , MILIONIS, V , IOANNOU, M , (2016) RECENT ADVANCES IN AGGRESSIVE LARGE B-CELL LYMPHOMAS: A COMPREHENSIVE REVIEW.ADVANCES IN ANATOMIC PATHOLOGY. VOL. 23. ISSUE 4. P. 202 -243 | 154 | 48% | 0 |
2 | TESTONI, M , ZUCCA, E , YOUNG, KH , BERTONI, F , (2015) GENETIC LESIONS IN DIFFUSE LARGE B-CELL LYMPHOMAS.ANNALS OF ONCOLOGY. VOL. 26. ISSUE 6. P. 1069 -1080 | 99 | 59% | 17 |
3 | ARAF, S , KORFI, K , RAHIM, T , DAVIES, A , FITZGIBBON, J , (2016) ADVANCES IN THE MOLECULAR DIAGNOSIS OF DIFFUSE LARGE B-CELL LYMPHOMA IN THE ERA OF PRECISION MEDICINE.EXPERT REVIEW OF MOLECULAR DIAGNOSTICS. VOL. 16. ISSUE 10. P. 1093 -1102 | 71 | 83% | 0 |
4 | HU, SM , XU-MONETTE, ZY , TZANKOV, A , GREEN, T , WU, L , BALASUBRAMANYAM, A , LIU, WM , VISCO, C , LI, Y , MIRANDA, RN , ET AL (2013) MYC/BCL2 PROTEIN COEXPRESSION CONTRIBUTES TO THE INFERIOR SURVIVAL OF ACTIVATED B-CELL SUBTYPE OF DIFFUSE LARGE B-CELL LYMPHOMA AND DEMONSTRATES HIGH-RISK GENE EXPRESSION SIGNATURES: A REPORT FROM THE INTERNATIONAL DLBCL RITUXIMAB-CHOP CONSORTIUM PROGRAM.BLOOD. VOL. 121. ISSUE 20. P. 4021-4031 | 38 | 88% | 130 |
5 | CAMICIA, R , WINKLER, HC , HASSA, PO , (2015) NOVEL DRUG TARGETS FOR PERSONALIZED PRECISION MEDICINE IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A COMPREHENSIVE REVIEW.MOLECULAR CANCER. VOL. 14. ISSUE . P. - | 151 | 25% | 9 |
6 | GREEN, TM , YOUNG, KH , VISCO, C , XU-MONETTE, ZY , ORAZI, A , GO, RS , NIELSEN, O , GADEBERG, OV , MOURITS-ANDERSEN, T , FREDERIKSEN, M , ET AL (2012) IMMUNOHISTOCHEMICAL DOUBLE-HIT SCORE IS A STRONG PREDICTOR OF OUTCOME IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RITUXIMAB PLUS CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, AND PREDNISONE.JOURNAL OF CLINICAL ONCOLOGY. VOL. 30. ISSUE 28. P. 3460-3467 | 30 | 91% | 188 |
7 | CARBONE, A , GLOGHINI, A , KWONG, YL , YOUNES, A , (2014) DIFFUSE LARGE B CELL LYMPHOMA: USING PATHOLOGIC AND MOLECULAR BIOMARKERS TO DEFINE SUBGROUPS FOR NOVEL THERAPY.ANNALS OF HEMATOLOGY. VOL. 93. ISSUE 8. P. 1263 -1277 | 60 | 63% | 16 |
8 | BELLAS, C , GARCIA, D , VICENTE, Y , KILANY, L , ABRAIRA, V , NAVARRO, B , PROVENCIO, M , MARTIN, P , (2014) IMMUNOHISTOCHEMICAL AND MOLECULAR CHARACTERISTICS WITH PROGNOSTIC SIGNIFICANCE IN DIFFUSE LARGE B-CELL LYMPHOMA.PLOS ONE. VOL. 9. ISSUE 6. P. - | 45 | 88% | 10 |
9 | LIN, P , MEDEIROS, LJ , (2013) THE IMPACT OF MYC REARRANGEMENTS AND "DOUBLE HIT" ABNORMALITIES IN DIFFUSE LARGE B-CELL LYMPHOMA.CURRENT HEMATOLOGIC MALIGNANCY REPORTS. VOL. 8. ISSUE 3. P. 243-252 | 47 | 87% | 13 |
10 | GIFFORD, GK , GILL, AJ , STEVENSON, WS , (2016) MOLECULAR SUBTYPING OF DIFFUSE LARGE B-CELL LYMPHOMA: UPDATE ON BIOLOGY, DIAGNOSIS AND EMERGING PLATFORMS FOR PRACTISING PATHOLOGISTS.PATHOLOGY. VOL. 48. ISSUE 1. P. 5 -16 | 64 | 60% | 1 |
Classes with closest relation at Level 1 |